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Abstract 
Pineal parenchymal tumors are rare. Of the
three  types  of  pineal  parenchymal  tumors,
pineocytomas are the least aggressive and are
not  known  to  diffusely  disseminate.  In  this
paper, we report the successful treatment of a
case  of  pineocytoma  with  diffuse  lep-
tomeningeal relapse following initial stereotac-
tic radiotherapy. A 39-year-old female presented
with headaches, balance impairment, urinary
incontinence, and blunted affect. A pineal mass
was discovered on magnetic resonance imaging
(MRI). A diagnosis of pineocytoma was estab-
lished with an endoscopic pineal gland biopsy,
and the patient received stereotactic radiother-
apy. Ten years later, she developed diffuse lep-
tomeningeal  dissemination.  The  patient  was
then successfully treated with craniospinal radi-
ation  therapy.  Leptomeningeal  spread  may
develop as late as 10 years after initial presenta-
tion of pineocytoma. Our case demonstrates the
importance of long-term follow-up of patients
with pineal parenchymal tumors following radi-
ation therapy, and the efficacy of craniospinal
radiation  in  the  treatment  of  leptomeningeal
dissemination. 
Introduction
Pineal  parenchymal  tumors  are  rare,
accounting  for  0.4-1%  of  all  intracranial
tumors in the United States and Europe and
2.2-8%  of  those  in  Northeast  Asia.1,2 Pineal
parenchymal  tumors  (PPT)  include  pineocy-
tomas, pineal parenchymal tumors of interme-
diate differentiation (PPTID), and pineoblas-
tomas.  Pineocytomas  typically  remain  local-
ized, and the reported 5-year survival rate is
86%.3,4 There  have  been  sparse  reports  of
pineocytomas associated with leptomeningeal
progression, but to our knowledge none have
described in detail the extent, time course, and
management  of  diffuse  leptomeningeal  dis-
semination.5,6 In this paper, we report a case of
pineocytoma with leptomeningeal relapse fol-
lowing radiotherapy.
Case Report
Presentation
In June 1999, a 39-year-old female present-
ed  with  a  two  year  history  of  worsening
headaches,  balance  impairment,  urinary
incontinence, and blunted affect, with a loss of
interest  in  her  usual  activities.  She  had  no
visual  complaints.  On  physical  exam,  pupils
were equal, round and reactive to light, and
extraocular movements were intact, including
upward gaze, with no evidence of Parinaud’s
syndrome. Magnetic resonance imaging (MRI)
demonstrated  a  heterogeneously  enhancing
pineal mass causing hydrocephalus (Figure 1).
Operation and diagnosis
An endoscopic pineal gland biopsy and third
ventriculostomy  were  performed.  The  biopsy
revealed a primary pineal neoplasm with uni-
form cells, round nuclei, and focal clusters of
cells consistent with pineocytomatous rosettes.
The  final  pathologic  diagnosis  was  pineocy-
toma.  The  patient  continued  to  experience
symptoms following the third ventriculostomy,
requiring  placement  of  a  ventriculoperitonal
shunt. Following shunt placement, her symp-
toms dramatically improved.
Treatment
In  October  1999,  the  patient  underwent
stereotactic radiotherapy to a total dose of 5040
cGy in 28 fractions of 180 cGy. The prescribed
90% isodose line encompassed the multi-locu-
lated contrast-enhancing volume of the tumor
with minimal additional margin. At the time of
treatment  planning,  the  target  volume  was
1.68 cc and measured approximately 13¥15¥
20 mm. Daily treatment was delivered by a ded-
icated 6-MV linear accelerator with micromul-
tileaf  collimators  (Novalis,  Heimstetten,
Germany). The patient was immobilized by a
custom-fitted  thermoplastic  face  mask.
Treatment  was  performed  using  a  single
isocenter and 17 noncoplanar beams, each of
which was conformed to the beam's eye view
of the target by the collimator. The patient tol-
erated  daily  immobilization  and  treatment
without acute complications.
Post-treatment course
The patient was followed with MR imaging.
The  enhancing  region  of  the  tumor  disap-
peared by June 2001. By June 2007, complete
resolution of the pineal mass was noted along
with  diffuse  pachymeningeal  thickening.
Given the non-specific nature of this finding in
an  otherwise  asymptomatic  patient,  regular
follow-up was scheduled in two years.
Recurrence
In  February  2009,  the  patient  returned  to
clinic complaining of bilateral resting tremors
and left hand numbness over the previous year,
progressive  low  back  pain  and  sciatica-like
pain running down her left leg into her left foot
for the past six months and constipation, nau-
sea, vomiting, fatigue and saddle anesthesia
increasing over the previous three weeks. She
had additionally experienced a twenty-pound
weight loss over the past three years. An MRI
was  performed  which  revealed  mass-like
enhancement of the fifth cranial nerve, wide-
spread leptomeningeal enhancement involving
the  cervical,  thoracic,  and  lumbar  spine,  as
well as enhancement throughout the perimes-
encephalic cistern, interpeducular cistern, and
cisterna magna (Figures 2 and 3). The imag-
ing revealed no evidence of local relapse.
Diagnosis and treatment
Cerebrospinal fluid studies revealed atypical
cells consistent with pineocytoma. There was
no  evidence  of  infection,  with  negligible
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leukocytes  and  negative  tests  for  syphilis,
cryptococcus,  tuberculosis  and  other  infec-
tious etiologies. In March 2009, a left frontal
craniotomy and dural biopsy were performed.
The biopsy was described as pineocytoma and
pineal parenchymal tumor of intermediate dif-
ferentiation, WHO grade II-III. The sample did
not  have  the  histopathologic  features  of  a
pineoblastoma,  according  to  the  WHO
Classification of Tumors affecting the Central
Nervous  System.  The  tumor  was  graded  as
WHO II-III in view of histologic characteristics
consistent with a pineocytoma and a high Ki-
67 index (10-15%). By the time the pathology
from the dural biopsy was reviewed, the slides
from the original biopsy were no longer avail-
able  for  comparison  or  additional  staining.
The patient began craniospinal radiation ther-
apy in April 2009, receiving 24 Gy in 16 frac-
tions  to  the  whole  brain  and  spine,  with  a
boost of 26 Gy to the sacral spine.
Follow-up
By June 2009, the patient's MRI revealed
decreased leptomeningeal enhancement and
a  decrease  in  the  size  of  the  trigeminal
nerves.  All  of  the  patient’s  symptoms  had
resolved except for minimal residual tremor.
The  patient  refused  adjuvant  chemotherapy.
The patient was last followed up more than 24
months after completion of craniospinal radi-
ation. At that time, she remained tumor free
and  had  a  normal  neurologic  examination,
except for minimal tremor. By 24 months post-
treatment, we would expect any late neurolog-
ic side effects to have already emerged. These
late side effects would likely consist of a verti-
cal gaze palsy secondary to radiation necrosis
and  edema  in  the  pineal  region,  which
received the highest radiation dose 50.4+24
Gy. This patient is unlikely to develop any late
neurologic side effects in the future.
Discussion
PPT are classified into three types: pineocy-
tomas,  PPTID,  and  pineoblastomas.
Pineocytomas  and  pineoblastomas  each
account  for  approximately  45%  of  pineal
parenchymal tumors.3 PPTID are tumors that
lie  on  the  spectrum  between  pineocytomas
and pineoblastomas, and account for approxi-
mately  10%  of  pineal  parenchymal  tumors.3
The reported survival rates of these tumors
vary  from  86%  5-year-survival  for  pineocy-
tomas to projected 1-year, 3-year, and 5-year
survival rates of 88%, 78%, and 58%, respec-
tively  for  all  other  pineal  parenchymal
tumors.7
Diffuse  leptomeningeal  enhancement  has
been reported in association with disseminat-
ed malignancies as well as benign etiologies
including  cerebrospinal  fluid  pressure
changes and autoimmune, infectious, inflam-
matory, and genetic disorders.8-13 In our case,
diffuse leptomeningeal enhancement was ini-
tially  thought  to  be  due  to  infection,  since
pineocytoma has a low risk of dissemination
to the leptomeninges and this type of diffuse
dissemination had not yet been reported in
the literature. 
D’Andrea  et  al.  reported  leptomeningeal
dissemination  in  three  of  six  children  with
pineocytomas, although it is unclear whether
the dissemination was focal or widespread.6
Additionally, the authors did not use the desig-
nation PPTID. They classified pineal tumors
only  as  pineocytoma  or  papillary  pineocy-
toma.6 It is, therefore, possible that some of
their  pineocytomas  were  actually  PPTID,  a
potentially more aggressive tumor. Two retro-
spective studies of pineal tumors reported by
Schild et al. found that of the PPT, spinal dis-
semination  was  associated  with  mixed  PPT
and  PPTID  but  not  pineocytomas.4,7 If
D’Andrea et al. had classified their cases into
pineocytomas and mixed PPT or PPTID, it is
possible  that  they  might  have  found  lep-
tomeningeal  dissemination  to  be  associated
with  mixed  PPT  and  PPTID  and  not  pure
pineocytoma.
Leptomeningeal dissemination in our case
could potentially be a result of dedifferentia-
tion  of  an  initial  pineocytoma  into  a  more
aggressive PPTID. In our case, however, this
scenario is less likely given that a dedifferen-
tiated tumor would not have the histological
characteristics of a pineocytoma.
It has been noted by Hasegawa et al. that an
extensive  amount  of  tissue  is  necessary  to
diagnose a PPTID, as opposed to a pineocy-
toma, and often stereotactic sampling or endo-
scopic sampling (as was used to obtain the
first biopsy specimen in this case) are not suf-
ficient.5 In our case, subsequent dural biopsy
revealed PPTID. It is possible that the original
tumor  had  regions  of  PPTID  which  were
missed in the biopsy, resulting in an unappre-
ciated risk for leptomeningeal dissemination.
A final possibility is that the endoscopic biop-
sy seeded the leptomeninges or served as a
trigger for later dissemination. 
Leptomeningeal spread, although rare, may
develop as late as 10 years after initial presen-
tation of pineocytoma. The natural history of
our case demonstrates the importance of long-
term follow-up of patients with pineal tumors
following  radiation  therapy  treatment.  As  is
demonstrated by our case, a patient that devel-
ops  leptomeningeal  dissemination  from  a
pineal parenchymal tumor can be effectively
treated with whole brain and spine radiation
therapy. 
Case Report
Figure 1. T1-weighted post-contrast sagit-
tal magnetic resonance image showing an
enhancing mass in the region of the pineal
gland.
Figure  2.  T1-weighted  post-contrast  axial
magnetic  resonance  image  showing  lep-
tomeningeal  enhancement  around  the
brainstem at the cervicomedullary junction.
Figure 3. T1-weighted post-contrast axial
magnetic resonance image showing nodu-
lar enlargement and enhancement of the
trigeminal nerves bilaterally.[Rare Tumors 2011; 3:e53] [page 165]
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